Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-813-4 | CAS number: 13494-80-9
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-05-08 to 2012-06-08
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Tellurium
- EC Number:
- 236-813-4
- EC Name:
- Tellurium
- Cas Number:
- 13494-80-9
- Molecular formula:
- Te
- IUPAC Name:
- tellurium
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): Tellurium
- Substance type: inorganic
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix; phenobarbital/β-naphthoflavoneinduced rat liver
- Test concentrations with justification for top dose:
- Range finding test: 5000, 2500, 1000, 316, 100, 31.6 and 10 μg/plate (TA 98 and TA 100 with and without metabolic activation).
Initial mutation test: 5000, 1581, 500, 158.1, 50, 15.81 and 5 μg test item/plate.
Confirmatory mutation test: 5000, 1581, 500, 158.1, 50, 15.81, 5 and 1.581 μg test item/plate.
Complementary confirmatory mutation test: 158.1; 50; 15.81; 5; 1.581, 0.5, 0.1581 and 0.05 μg test item/plate. - Vehicle / solvent:
- 1 % (v/v) methyl cellulose solution was used as vehicle to prepare the stock formulation of the test material.
Test formulations were freshly prepared at the beginning of the experiments in the testing laboratory by
diluting the stock formulation using the selected vehicle.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-1,2-phenylenediamine (NPD); 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Preliminary and initial experiment: in agar (plate incorporation)
For confirmatory and complementary confirmatory tests preincubation method was used
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h
SELECTION AGENT (mutation assays):
NUMBER OF REPLICATIONS: 3 plates/concentration - Evaluation criteria:
- Criteria for Validity:
The study was considered valid if:
- the number of revertant colonies of the negative (vehicle/solvent) and positive controls were in the historical control range in all strains of the main tests;
- at least five analyzable concentrations were presented in all strains of the main tests.
Criteria for a Positive Response:
A test item was considered mutagenic if:
- a dose–related increase in the number of revertants occurred and/or;
- a reproducible biologically relevant positive response for at least one of the dose groups occurred in at least one strain with or without metabolic
activation.
An increase was considered biologically relevant if:
- in all strains: the number of reversion was more than twice higher than the reversion rate of the vehicle control.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Based on the results of the Preliminary Solubility Test, 1 % (v/v) methyl cellulose solution was selected for vehicle of the test item in the study. Concentrations of 5000; 2500; 1000; 316; 100; 31.6 and 10 μg/plate were examined in the Preliminary Range Finding Test. Based on the results of the Preliminary Range Finding Test, the test item concentrations in the Initial Mutation Test were 5000, 1581, 500, 158.1, 50, 15.81 and 5 μg test item/plate. Examined concentrations in the Confirmatory Mutation Test were 5000, 1581, 500, 158.1, 50, 15.81, 5 and 1.581 μg test item/plate. Examined concentrations in the Complementary Confirmatory Mutation Test were 158.1; 50; 15.81; 5; 1.581, 0.5, 0.1581 and 0.05 μg test item/plate.
In the Initial Mutation Test, Confirmatory Mutation Test and Complementary Confirmatory Mutation Test, none of the observed revertant colony numbers were above the respective biological threshold value. There were no consistent dose-related trends and no indication of any treatment effect. In all test item treated groups, the numbers of revertant colonies were below the biological relevance when compared with the solvent controls and were within the historical control range and were within the normal biological variability of the test system.
Slight inhibitory, cytotoxic effect of the test item was observed in the Initial Mutation Test in Salmonella typhimurium TA98 bacterial strain at 5000 μg/plate concentration with metabolic activation and in Escherichia coli WP2 uvrA bacterial strain at 5000 μg/plate concentration without metabolic activation. Reduced numbers of revertant colonies compared to the vehicle control plates were also observed in Salmonella typhimurium TA100 strain at 5000 μg/plate concentration without metabolic activation, and in Salmonella typhimurium TA1535 and Escherichia coli WP2 uvrA strains at 5000 μg/plate concentration with metabolic activation, although no effect on the background lawn was observed.
Similar, but stronger cytotoxic effect was observed using the pre-incubation method (Confirmatory Mutation Test and Complementary Confirmatory Mutation Test) in Salmonella typhimurium TA100, TA1535 and TA1537 strains at 158.1 and 50 μg/plate concentrations without metabolic activation; and in Escherichia coli WP2 uvrA strain at 5000, 1581 and 500 μg/plate concentrations without metabolic activation.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
In conclusion, the test item Tellurium had no mutagenic activity in the bacterium tester strains under the test conditions used in this study. - Executive summary:
In a reverse gene mutation assay in bacteria according to OECD guideline 471, strains TA 1535, TA 1537, TA98 and TA100 of S. typhimurium and E. coli WP2 uvrA were exposed to Tellurium, (powder 99.95 % a.i.), at concentrations up to 5000 µg/plate in the presence and absence of mammalian metabolic activation, (S9 mix; phenobarbital/β-naphthoflavone induced rat liver).
The initial Mutation Test was performed as plate incorporation method; the confirmatory and complementary assays were performed according to the pre-incubation method.
In the Initial Mutation Test, Confirmatory Mutation Test and Complementary Confirmatory Mutation Test, none of the observed revertant colony numbers were above the respective biological threshold value. There were no consistent dose-related trends and no indication of any treatment effect. In all test item treated groups, the numbers of revertant colonies were below the biological relevance when compared with the solvent controls and were within the historical control range and were within the normal biological variability of the test system.
Slight inhibitory, cytotoxic effect of the test item was observed in the Initial Mutation Test in Salmonella typhimurium TA98 bacterial strain at 5000 μg/plate concentration with metabolic activation and in Escherichia coli WP2 uvrA bacterial strain at 5000 μg/plate concentration without metabolic activation. Reduced numbers of revertant colonies compared to the vehicle control plates were also observed in Salmonella typhimurium TA100 strain at 5000 μg/plate concentration without metabolic activation, and in Salmonella typhimurium TA1535 and Escherichia coli WP2 uvrA strains at 5000 μg/plate concentration with metabolic activation, although no effect on the background lawn was observed.
Similar, but stronger cytotoxic effect was observed using the pre-incubation method (Confirmatory Mutation Test and Complementary Confirmatory Mutation Test) in Salmonella typhimurium TA100, TA1535 and TA1537 strains at 158.1 and 50 μg/plate concentrations without metabolic activation; and in Escherichia coli WP2 uvrA strain at 5000, 1581 and 500 μg/plate concentrations without metabolic activation.
The mean values of revertant colonies of the solvent control plates were within the historical control range, the reference mutagens showed the expected increase in the number of revertant colonies, the viability of the bacterial cells was confirmed by a plating experiment in each test. At least five analyzable concentrations were presented in all strains of the main tests. The tests were considered to be valid.
In conclusion there was no evidence of induced mutant colonies over background.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
